Gene Therapy in Peripheral Blood Lymphocytes and Bone Marrow for ADA− Immunodeficient Patients

Adenosine deaminase (ADA) deficiency results in severe combined immunodeficiency, the first genetic disorder treated by gene therapy. Two different retroviral vectors were used to transfer ex vivo the human ADA minigene into bone marrow cells and peripheral blood lymphocytes from two patients undergoing exogenous enzyme replacement therapy. After 2 years of treatment, long-term survival of T and B lymphocytes, marrow cells, and granulocytes expressing the transferred ADA gene was demonstrated and resulted in normalization of the immune repertoire and restoration of cellular and humoral immunity. After discontinuation of treatment, T lymphocytes, derived from transduced peripheral blood lymphocytes, were progressively replaced by marrow-derived T cells in both patients. These results indicate successful gene transfer into long-lasting progenitor cells, producing a functional multilineage progeny.

[1]  E. Linney,et al.  Suppression of leukaemia virus pathogenicity by polyoma virus enhancers , 1985, Nature.

[2]  R. Mulligan,et al.  The basic science of gene therapy. , 1993, Science.

[3]  B. Sullenger,et al.  Improved gene expression upon transfer of the adenosine deaminase minigene outside the transcriptional unit of a retroviral vector. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[4]  F. Davis,et al.  Treatment of L5178Y tumor-bearing BDF1 mice with a nonimmunogenic L-glutaminase-L-asparaginase. , 1979, Cancer treatment reports.

[5]  T. Small,et al.  The use of HLA-non-identical T-cell-depleted marrow transplants for correction of severe combined immunodeficiency disease. , 1989, Immunodeficiency reviews.

[6]  C. Bordignon,et al.  Peripheral Blood Lymphocytes as Target Cells of Retroviral Vector-Mediated Gene Transfer , 1994 .

[7]  J. Ihle,et al.  Gene marking to determine whether autologous marrow infusion restores long-term haemopoiesis in cancer patients , 1993, The Lancet.

[8]  E. Gilboa,et al.  Transfer of the ADA gene into bone marrow cells and peripheral blood lymphocytes for the treatment of patients affected by ADA-deficient SCID. , 1993, Human gene therapy.

[9]  Antonio Lanzavecchia,et al.  Antigen-specific interaction between T and B cells , 1985, Nature.

[10]  F. Rosen,et al.  Bone marrow transplantation only partially restores purine metabolites to normal in adenosine deaminase-deficient patients. , 1981, The Journal of clinical investigation.

[11]  R. Parkman.  The application of bone marrow transplantation to the treatment of genetic diseases. , 1986, Science.

[12]  K. Cornetta,et al.  Lymphocytes as cellular vehicles for gene therapy in mouse and man. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[13]  R. Kobayashi,et al.  Treatment of adenosine deaminase deficiency with polyethylene glycol-modified adenosine deaminase. , 1987, The New England journal of medicine.

[14]  T. Friedmann,et al.  Progress toward human gene therapy. , 1989, Science.

[15]  E. Gilboa,et al.  Retroviral vector-mediated high-efficiency expression of adenosine deaminase (ADA) in hematopoietic long-term cultures of ADA-deficient marrow cells. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[16]  P Berg,et al.  Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter. , 1982, Journal of molecular and applied genetics.

[17]  M. Hershfield,et al.  Adenosine deaminase deficiency with late onset of recurrent infections: response to treatment with polyethylene glycol-modified adenosine deaminase. , 1988, The Journal of pediatrics.

[18]  B. Dupont,et al.  Transplantation for severe combined immunodeficiency with HLA-A,B,D,DR incompatible parental marrow cells fractionated by soybean agglutinin and sheep red blood cells. , 1983, Blood.

[19]  W. Anderson,et al.  Gene-marking to trace origin of relapse after autologous bone-marrow transplantation , 1993, The Lancet.

[20]  K. Cornetta,et al.  Human gene transfer: characterization of human tumor-infiltrating lymphocytes as vehicles for retroviral-mediated gene transfer in man. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[21]  A. Nienhuis,et al.  Retrovirally marked CD34-enriched peripheral blood and bone marrow cells contribute to long-term engraftment after autologous transplantation. , 1995, Blood.

[22]  E. Giblett,et al.  Adenosine-deaminase deficiency in two patients with severely impaired cellular immunity. , 1972, Lancet.

[23]  C. von Kalle,et al.  Increased gene transfer into human hematopoietic progenitor cells by extended in vitro exposure to a pseudotyped retroviral vector. , 1994, Blood.

[24]  P. Marrack,et al.  Interaction of Staphylococcus aureus toxin "superantigens" with human T cells. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[25]  S. Mineishi,et al.  Ex vivo expansion and selection of human CD34+ peripheral blood progenitor cells after introduction of a mutated dihydrofolate reductase cDNA via retroviral gene transfer. , 1995, Blood.

[26]  R. Stern,et al.  Enzyme replacement therapy for adenosine deaminase deficiency and severe combined immunodeficiency. , 1976, The New England journal of medicine.

[27]  Antonio Lanzavecchia,et al.  Universally immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cells , 1989, European journal of immunology.

[28]  M. Hershfield,et al.  Enzyme Replacement Therapy with Polyethylene Glycol-Adenosine Deaminase in Adenosine Deaminase Deficiency: Overview and Case Reports of Three Patients, Including Two Now Receiving Gene Therapy , 1993, Pediatric Research.

[29]  L. Lanier,et al.  Polymerase chain reaction with single-sided specificity: analysis of T cell receptor delta chain. , 1989, Science.

[30]  E. Gilboa,et al.  An in vivo model of somatic cell gene therapy for human severe combined immunodeficiency. , 1991, Science.

[31]  Sutherland,et al.  Autografting with cultured marrow in chronic myeloid leukemia: results of a pilot study. , 1994, Blood.